Group One Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Group One Trading's XBI Position: Q3 2026 in Review
Group One Trading opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 219,540 shares worth $34.6M. The stake represents 0.05% of the portfolio and ranks #309 among its holdings. This is a return to the name: Group One Trading previously reported a position in XBI as recently as Q1 2026.
Group One Trading first reported a position in XBI in Q1 2025 and has held it in 4 quarters since. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Group One Trading held 219,540 shares of State Street SPDR S&P Biotech ETF worth $34.6M as of Q3 2026.
- State Street SPDR S&P Biotech ETF was a new Group One Trading position in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.05% of Group One Trading's portfolio in Q3 2026, its #309 holding.
- Group One Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 4 quarters since.
- 604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.